BMJ 1999;318:1138 ( 24 April )

Letters

Clinical trials

    Simple megatrials are not sufficient
    Randomised database studies could serve as new strategy

Simple megatrials are not sufficient

The first 150 words of the full text of this article appear below.

EDITOR---No one should argue with Peto and Baigent about the dangers of basing clinical practice on flawed "outcomes research" or isolated, undersized, randomised trials,1 but the simple megatrial may not be the ideal model for the next 50 years. Although such trials have taught us not to expect a predictable physiological response from our treatments but merely an improvement in the odds of successful outcome, the homogenising effect of large numbers may still disguise important variations in response. Attempts to explore these variations through subgroup analysis are widely condemned because of the perceived association with retrospective data dredging, so that the theoretical knowledge of clinicians and the individuality of patients are seen as increasingly less relevant to decisions about treatment.

The trials that Peto and Baigent advocate focus on hard end points, such as deaths, which may be rare in some patient groups and of limited relevance in others. . . . [Full text of this article]
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to StumbleUpon StumbleUpon   Add to Technorati Technorati    What's this?

Relevant Article

Trials: the next 50 years
Richard Peto and Colin Baigent
BMJ 1998 317: 1170-1171. [Extract] [Full Text] [PDF]

This article has been cited by other articles:

  • Hilbrich, L., Sleight, P. (2006). Progress and problems for randomized clinical trials: from streptomycin to the era of megatrials. Eur Heart J 27: 2158-2164 [Abstract] [Full text]  
Access jobs at BMJ Careers
Whats new online at Student BMJ